Euclidean Capital as of June 30, 2026
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 11 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vanguard Intl Equity Index F Allwrld Ex Us (VEU) | 61.8 | $272M | 3.2M | 83.75 | |
| Vanguard Index Fds Value Etf (VTV) | 25.8 | $113M | 520k | 217.93 | |
| Ishares Tr Msci India Etf (INDA) | 4.2 | $18M | 370k | 49.39 | |
| Oric Pharmaceuticals (ORIC) | 2.4 | $11M | 989k | 10.83 | |
| Teamshares | 2.1 | $9.0M | 1.1M | 8.22 | |
| Foghorn Therapeutics (FHTX) | 1.7 | $7.7M | 1.6M | 4.88 | |
| Pmv Pharmaceuticals (PMVP) | 0.8 | $3.5M | 2.6M | 1.34 | |
| Alector (ALEC) | 0.6 | $2.6M | 1.3M | 2.01 | |
| Surrozen Com New (SRZN) | 0.5 | $2.3M | 88k | 25.95 | |
| Tenaya Therapeutics (TNYA) | 0.2 | $751k | 1.0M | 0.74 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $2.8k | 171k | 0.02 |
